Arkolith/Insider Trading/DMAX/Form 4

Pauls Dietrich John

President and CEO, DirectorDiaMedica Therapeutics Inc. (DMAX) · full profile →Form 4 · filed Nov 16, 2022
Net Buying
Open-Market Buys
$24K
Open-Market Sells
$0
Net Open-Market Flow
$24K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 16, 2022Buy(P)20K$1.21$24K56K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001235802-22-000121) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML